BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24253403)

  • 61. Adherence to Quality of Care Indicators and Location of Sickle Cell Care Within Indiana.
    Meier ER; Janson IA; Hampton K; Bloom E; Duncan N; Roberson C; Rampersad A
    J Community Health; 2020 Feb; 45(1):81-87. PubMed ID: 31396825
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identifying sickle cell disease cases using administrative claims.
    Reeves S; Garcia E; Kleyn M; Housey M; Stottlemyer R; Lyon-Callo S; Dombkowski KJ
    Acad Pediatr; 2014; 14(5 Suppl):S61-7. PubMed ID: 24882379
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of a guideline-based best practice alert on pneumococcal vaccination rates in adults in a primary care setting.
    McAdam-Marx C; Tak C; Petigara T; Jones NW; Yoo M; Briley MS; Gunning K; Gren L
    BMC Health Serv Res; 2019 Jul; 19(1):474. PubMed ID: 31291959
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions.
    Carter R; Wolf J; van Opijnen T; Muller M; Obert C; Burnham C; Mann B; Li Y; Hayden RT; Pestina T; Persons D; Camilli A; Flynn PM; Tuomanen EI; Rosch JW
    Cell Host Microbe; 2014 May; 15(5):587-599. PubMed ID: 24832453
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Infection caused by Streptococcus pneumoniae in children with sickle cell disease: epidemiology, immunologic mechanisms, prophylaxis, and vaccination.
    Wong WY; Overturf GD; Powars DR
    Clin Infect Dis; 1992 May; 14(5):1124-36. PubMed ID: 1600015
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Anti-pneumococcal vaccine coverage for hospitalized risk patients: Assessment and suggestions for improvements].
    Richard C; Le Garlantezec P; Lamand V; Rasamijao V; Rapp C
    Ann Pharm Fr; 2016 May; 74(3):244-51. PubMed ID: 26619926
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influenza vaccination rates and hospitalizations among Medicaid enrollees with and without sickle cell disease, 2009-2015.
    Payne AB; Adamkiewicz TV; Grosse SD; Steffens A; Shay DK; Reed C; Schieve LA
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29351. PubMed ID: 34542932
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Unswitched memory B cell deficiency in children with sickle cell disease and response to pneumococcal polysaccharide vaccine.
    Tubman VN; Maysonet D; Estrada N; Halder T; Ramos L; Bhamidipati S; Carisey AF; Minard CG; Allen CE
    Am J Hematol; 2024 Jun; 99(6):1084-1094. PubMed ID: 38708915
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A quality improvement study: Optimizing pneumococcal vaccination rates in children with cochlear implants.
    Tay S; Bowen AC; Blyth CC; Clifford P; Clack R; Ford T; Herbert H; Kuthubutheen J; Mascaro F; O'Mahoney A; Rodrigues S; Tran T; Campbell AJ
    Vaccine; 2022 Jul; 40(32):4531-4537. PubMed ID: 35718588
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD).
    Mupfudze TG; Preussler JM; Sees JA; SanCartier M; Arnold SD; Devine S
    Transplant Cell Ther; 2021 Apr; 27(4):345-351. PubMed ID: 33836889
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vaccine shot-limiting: Estimating the prevalence, indicators, and impact on vaccination status - Michigan, 2012.
    Weinberg M; Dietz S; Potter R; Swanson R; Miller C; McFadden J
    Vaccine; 2017 Feb; 35(7):1018-1023. PubMed ID: 28108229
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Implementing a Multidisciplinary Approach to Enhance Compliance With Guideline-Recommended Prechemotherapy Pneumococcal Vaccination in a Military-Based Medical Oncology Practice.
    Delacruz W; Terrazzino S; Osswald M; Payne C; Haney B
    J Oncol Pract; 2017 Nov; 13(11):e966-e971. PubMed ID: 28876159
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Uptake of pneumococcal conjugate vaccine: methodological issues in measurement and impact of publicly funded programs.
    De Wals P; Boulianne N; Sévin E; Ouakki M; Deceuninck G; Guay M
    Can J Public Health; 2009; 100(6):413-6. PubMed ID: 20209732
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica.
    Brown BJ; Madu A; Sangeda RZ; Nkya S; Peprah E; Paintsil V; Mmbando BP; Gyamfi J; Okocha CE; Asala SA; Nembaware V; Jonas M; Kengne AP; Chimusa ER; Nguweneza A; Isa HA; Nnebe-Agumadu U; Adekile AD; Osei-Akoto A; Ohene-Frempong K; Balandya E; Nnodu OE; Wonkam A; Makani J;
    Hemoglobin; 2021 May; 45(3):163-170. PubMed ID: 34355623
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of the Vaccines for Children program on physician referral of children to public vaccine clinics: a pre-post comparison.
    Zimmerman RK; Mieczkowski TA; Mainzer HM; Medsger AR; Raymund M; Ball JA; Jewell IK
    Pediatrics; 2001 Aug; 108(2):297-304. PubMed ID: 11483791
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Pneumococcal vaccination coverage in at-risk children in Catalonia].
    González R; Armadans L; Martínez X; Moraga F; Campins M
    Enferm Infecc Microbiol Clin; 2015 Nov; 33(9):597-602. PubMed ID: 25703208
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preventing Infections in Sickle Cell Disease: The Unfinished Business.
    Obaro SK; Iroh Tam PY
    Pediatr Blood Cancer; 2016 May; 63(5):781-5. PubMed ID: 26840500
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Primary care follow-up of newborns with sickle cell disease detected in neonatal screening in the Community of Madrid].
    Rodríguez-Moldes B; Carbajo AJ; Sánchez B; Fernández M; Garí M; Fernández MC; Álvarez J; García A; Cela E
    An Pediatr (Barc); 2015 Apr; 82(4):222-7. PubMed ID: 24840253
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Primary prevention in the intensive care unit: a prospective single-centre study of the risk factors for invasive pneumococcal disease.
    Chapman AR; Litton EL
    Anaesth Intensive Care; 2017 Jul; 45(4):448-452. PubMed ID: 28673213
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time.
    Sprenger R; Häckl D; Kossack N; Schiffner-Rohe J; Wohlleben J; von Eiff C
    PLoS One; 2022; 17(3):e0265433. PubMed ID: 35316288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.